ANIP
ANI Pharmaceuticals, Inc.
NASDAQ · USHealthcareDrug Manufacturers - Specialty & Generic
$77.72-1.87%
Price as of Jul 20, 2026
ANIP profitability
ANI Pharmaceuticals, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 65.9%
- EBITDA margin
- 25.4%
- EBIT margin
- 13.4%
- Net margin
- 9.7%
- Free cash flow margin
- 17.4%
Returns
- Return on equity
- 15.9%
- Return on assets
- 6.3%
- Return on invested capital
- 13.9%
- Asset turnover
- 0.65x
Cash efficiency
- Cash from operations
- $208.6M
- Cash per share
- $14
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.